Skip to nav Skip to content

Sleep Medicine Clinical Trials

TAK-360-2001

Conditions: Narcolepsy Type 2

Type of Research: Interventional

Principle Investigator: Michael Strunc, MD

Study Specifications: The TAK-360-2001 trial will assess the effects of investigational drug TAK-360 on patients with diagnosed Type 2 Narcolepsy.

Email: CRU@chkd.org
Phone: (757) 668-5416


TAK-360-2002

Conditions: Idiopathic Hypersomnia

Type of Research: Interventional

Principle Investigator: Michael Strunc, MD

Study Specifications: The TAK-360-2002 trial will assess the effects of investigational drug TAK-360 on patients with diagnosed Idiopathic Hypersomnia.

Email: CRU@chkd.org
Phone: (757) 668-5416


TAK-861-2003

Conditions: Selected Central Hypersomnia

Type of Research: Interventional

Principle Investigator: Michael Strunc, MD

Study Specifications: The TAK-861-2003 trial will assess the effects of investigational drug TAK-861 on patients with selected central hypersomnia conditions.

Email: CRU@chkd.org
Phone: (757) 668-5416